Geode Capital Management, LLC Biofrontera Inc. Transaction History

Geode Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.4 - $0.65 $726 - $1,179	-1,815 Reduced 2.18%	81,282 $42,000
Q4 2022 Feb 13, 2023	BUY	$0.77 - $24.8 $6,995 - $225,308	9,085 Added 12.28%	83,097 $76,000
Q2 2022 Aug 12, 2022	BUY	$37.2 - $99.2 $376,203 - $1 Million	10,113 Added 15.83%	74,012 $137,000
Q1 2022 May 13, 2022	BUY	$45.0 - $138.4 $1.78 Million - $5.48 Million	39,621 Added 163.2%	63,899 $212,000
Q4 2021 Feb 11, 2022	BUY	$49.4 - $263.4 $1.2 Million - $6.39 Million	24,278 New	24,278 $182,000

Ticker BFRI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 23,551,000
Market Cap $22.6M
Description
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.